N/A
Manufactured by BM Private Limited
41 FDA adverse event reports analyzed
Last updated: 2026-04-15
POTASSIUM DICHROMATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by BM Private Limited. The most commonly reported adverse reactions for POTASSIUM DICHROMATE include DRUG HYPERSENSITIVITY, FATIGUE, PAIN, ABDOMINAL PAIN UPPER, ANAEMIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for POTASSIUM DICHROMATE.
Out of 6 classified reports for POTASSIUM DICHROMATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 41 FDA FAERS reports that mention POTASSIUM DICHROMATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG HYPERSENSITIVITY, FATIGUE, PAIN, ABDOMINAL PAIN UPPER, ANAEMIA, ANOREXIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list BM Private Limited in connection with POTASSIUM DICHROMATE. Always verify the specific product and NDC with your pharmacist.